{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:10:13Z","timestamp":1791090613313,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.ando.2009.03.002","type":"journal-article","created":{"date-parts":[[2009,4,5]],"date-time":"2009-04-05T03:34:30Z","timestamp":1238902470000},"page":"107-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Does first-line surgery still have its place in the treatment of acromegaly?"],"prefix":"10.1016","volume":"70","author":[{"given":"F.","family":"Castinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Albarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Conte-Devolx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2009.03.002_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11154-007-9064-y","article-title":"Surgery for acromegaly: evolution of the techniques and outcomes","volume":"9","author":"Laws","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ando.2009.03.002_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/eje.1.02036","article-title":"Consensus statement: medical management of acromegaly","volume":"153","author":"Melmed","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib3","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ando.2009.03.002_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000095533","article-title":"Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1000\u00a0operations","volume":"83","author":"Ludecke","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2009.03.002_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3171\/jns.2006.104.6.899","article-title":"Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates","volume":"104","author":"Losa","year":"2006","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2009.03.002_bib6","first-page":"1239","article-title":"Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98\u00a0patients","volume":"48","author":"Shimon","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2009.03.002_bib7","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/qjmed\/92.12.741","article-title":"Outcome of surgery for acromegaly \u2013 the experience of a dedicated pituitary surgeon","volume":"92","author":"Gittoes","year":"1999","journal-title":"QJM"},{"key":"10.1016\/j.ando.2009.03.002_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.surneu.2005.11.063","article-title":"A prospective analysis of 151\u00a0cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23\u00a0years","volume":"66","author":"Abbassioun","year":"2006","journal-title":"Surg Neurol"},{"key":"10.1016\/j.ando.2009.03.002_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01863","article-title":"The outcome of surgery in 668\u00a0patients with acromegaly using current criteria of biochemical \u201ccure\u201d","volume":"152","author":"Nomikos","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","article-title":"Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly","volume":"58","author":"Beauregard","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib11","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1210\/jcem.83.10.5111","article-title":"Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results","volume":"83","author":"Abosch","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/jns.1998.89.3.0353","article-title":"Long-term endocrinological follow-up evaluation in 115\u00a0patients who underwent transsphenoidal surgery for acromegaly","volume":"89","author":"Freda","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ando.2009.03.002_bib13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1530\/eje.0.1500763","article-title":"Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly","volume":"150","author":"Bourdelot","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-005-3280-9","article-title":"Outcome of surgery for acromegaly performed by different surgeons: importance of surgical experience","volume":"8","author":"Erturk","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2009.03.002_bib15","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996\u20132000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib16","first-page":"3034","article-title":"Octreotide as primary therapy for acromegaly","volume":"83","author":"Newman","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib17","first-page":"2779","article-title":"Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly","volume":"86","author":"Colao","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib18","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/jc.2003-030110","article-title":"Four-year treatment with octreotide-long-acting repeatable in 110\u00a0acromegalic patients: predictive value of short-term results?","volume":"88","author":"Cozzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib19","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1210\/jc.2003-030266","article-title":"Lanreotide\u00a060mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly","volume":"88","author":"Attanasio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib20","doi-asserted-by":"crossref","unstructured":"Ayuk J, Stewart SE, Stewart PM, Sheppard MC. Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and\/or radiotherapy. Clin Endocrinol 2004;60:375\u201381.","DOI":"10.1111\/j.1365-2265.2004.01992.x"},{"key":"10.1016\/j.ando.2009.03.002_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.1.01824","article-title":"Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs","volume":"152","author":"Petrossians","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2005-1208","article-title":"Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly","volume":"91","author":"Colao","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1365-2265.2007.03139.x","article-title":"Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide","volume":"68","author":"Karavitaki","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2007.02885.x","article-title":"Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?","volume":"67","author":"Jallad","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib25","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1210\/jcem.82.10.4283","article-title":"Effect of octreotide pretreatment on surgical outcome in acromegaly","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-2265.2003.01741.x","article-title":"Preoperative lanreotide treatment for GH-secreting pituitary adenomas: effect on tumour volume and predictive factors of significant tumour shrinkage","volume":"58","author":"Lucas","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/eje.0.1450137","article-title":"Effects of preoperative octreotide treatment on different subtypes of 90\u00a0GH-secreting pituitary adenomas and outcome in one surgical centre","volume":"145","author":"Abe","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00000542-200007000-00020","article-title":"Difficult intubation in acromegalic patients: incidence and predictability","volume":"93","author":"Schmitt","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ando.2009.03.002_bib29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1213\/01.ane.0000166976.61650.ae","article-title":"Perioperative management of patients undergoing transsphenoidal pituitary surgery","volume":"101","author":"Nemergut","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ando.2009.03.002_bib30","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1210\/jcem.85.12.7042","article-title":"Ten-year follow-up results of transsphenoidal microsurgery in acromegaly","volume":"85","author":"Biermasz","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s007010050316","article-title":"Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study","volume":"141","author":"Kristof","year":"1999","journal-title":"Acta neurochir (Wien)"},{"key":"10.1016\/j.ando.2009.03.002_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2265.2001.01351.x","article-title":"Are patients with acromegaly at high risk for dysrhythmias?","volume":"55","author":"Colao","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2009.03.002_bib33","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1210\/jc.2008-0299","article-title":"Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy","volume":"93","author":"Colao","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib34","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1210\/jc.2008-0315","article-title":"Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial","volume":"93","author":"Carlsen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2009.03.002_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0026-0495(96)90088-8","article-title":"Presurgical octreotide: treatment in acromegaly","volume":"45","author":"Stevenaert","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2009.03.002_bib36","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2008-1351","article-title":"Does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question","volume":"93","author":"Beckers","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342660900064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342660900064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:42:59Z","timestamp":1757716979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342660900064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S000342660900064X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2009.03.002","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does first-line surgery still have its place in the treatment of acromegaly?","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2009.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2008.12.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}